dacarbazine,doxorubicin,nivolumab,brentuximab vedotin,vinblastine,dexamethasone,cyclophosphamide
bms,seagen
['hodgkin']
excellent short thread about all the big news in hodgkin primary therapy at 17icml, 2023: 
Oncologist at Uppsala university hospital. Chair of the Swedish lymphoma group (SLG) and the Swedish Hodgkin lymphoma group.